Anterix Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Anterix Inc. on September 16, 2026. The report details a corporate action authorized by the Board of Directors regarding a new share repurchase program effective September 22, 2026.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization of up to $250,000,000 for the repurchase of the Company's common stock.
Material Changes
- Share Repurchase Authorization: The Board authorized a new program to replace the previous one expiring on September 21, 2026.
- Program Terms: The Company may repurchase shares on or before September 22, 2029.
- Execution Method: Repurchases may occur via open market or privately negotiated transactions, potentially under Rule 10b5-1 plans.
Guidance, Outlook, and Risks
Management indicated that the timing and amount of repurchases will depend on general business and market conditions, the Company's capital position, and strategic considerations. The filing explicitly states that the program does not obligate the Company to repurchase any specific amount and may be suspended, discontinued, or modified at any time.
Investor Verification Checklist
- Verify the exact expiration date of the previous share repurchase program (September 21, 2026) and the start date of the new program (September 22, 2026).
- Confirm the total authorized amount of $250,000,000 and the final expiration date of September 22, 2029.
- Review subsequent filings for actual repurchase activity, as the program is discretionary.
- Check the Company's current capital position to assess the impact of potential repurchases on liquidity.